Introduction
============

Acute onset kidney disease induced by infectious events has been recognized since the 19th century and is today extensively characterized and incorporated into our understanding of the pathophysiology of kidney disease.[@b1-clep-10-971] Despite increasing interest in the long-term effects of infections such as pneumonia, our knowledge in this area is incomplete for delayed risk of chronic kidney disease (CKD).[@b2-clep-10-971]--[@b6-clep-10-971] Our review of the literature revealed only one study assessing the long-term risk of CKD following pneumonia, which investigated pneumococcal pneumonia and end-stage renal disease (ESRD) in Taiwan.[@b7-clep-10-971]

Pneumonia affects 1.2% of the population in the northern hemisphere each year and constitutes the leading diagnosis requiring inpatient care in the US with approximately one million hospital admissions in the European Union annually.[@b8-clep-10-971]--[@b10-clep-10-971] Primary prevention is use of vaccines for the most important pathogen in community-acquired pneumonia, *Pneumococcus pneumoniae.* Pneumonia is associated with an increased risk of mortality, cardiovascular disease (CVD) and congestive heart failure for more than 10 years following infection.[@b2-clep-10-971]--[@b6-clep-10-971],[@b11-clep-10-971] Temporal patterns with initial higher magnitude risks during the first 3--5 years have been identified for all-cause mortality and CVD while the temporal pattern for congestive heart failure risk is less consistent.[@b2-clep-10-971]--[@b5-clep-10-971],[@b11-clep-10-971] The magnitude and persistence of the inflammatory response to pneumonia are associated with these adverse outcomes.[@b6-clep-10-971],[@b12-clep-10-971],[@b13-clep-10-971] Markers of raised inflammation levels have been associated with a higher risk of subsequent incident CKD, including our previous findings linking erythrocyte sedimentation rate in apparently healthy adolescent men with subsequent ESRD in middle age.[@b14-clep-10-971]--[@b17-clep-10-971] Thus, inflammation and vascular disease, resulting from serious infections, may trigger not only acute post-infectious glomerulonephritis but also possibly initiate processes resulting in delayed kidney disease diagnosed several years later.[@b1-clep-10-971] CKD is a public health issue of increasing importance throughout the world and is an important cause of death and loss of disability-adjusted life years.[@b18-clep-10-971] Therefore, if there is a period of heightened risk of disease onset during the years immediately following pneumonia, this may represent a target period for earlier diagnosis followed by secondary preventive interventions.

We examined whether an inpatient diagnosis of pneumonia in adult life is associated with a persistent risk of subsequent CKD in a representative birth cohort of 284,198 men followed into middle age, using routinely collected health data in national Swedish registers. To avoid surveillance bias and detecting acute pneumonia-related kidney complications, the main follow-up began 1 year after the pneumonia episode.

Materials and methods
=====================

Setting and participants
------------------------

A cohort of all male residents in Sweden born from 1952 to 1956 (n=284,198) who attended mandatory military conscription examinations in late adolescence (n=264,951) was identified and followed up till December 31, 2009, using Swedish National Registers. ICD-8/9/10 codes, procedure codes and ATC codes for prescribed medications are presented in [Table S1](https://www.dovepress.com/get_supplementary_file.php%3Ff%3D169039.pdf). All procedures involving patients and data were in accordance with the Helsinki Declaration of 1975 on ethical principles for medical research involving human subjects.[@b19-clep-10-971] The study was approved by the ethical review board of Uppsala, Sweden (numbers 2009/306 and 2014/324), which waived informed consent as the data were anonymized. Reporting of the study is in accordance with the STROBE statement.[@b20-clep-10-971]

The Total Population Register provided dates of birth, death and emigration. The Swedish Military Conscription Register provided information on physical and psychological characteristics and diagnoses by late adolescence. The 1960 Population and Housing Census provided familial socioeconomic data during childhood. Routinely collected health data were extracted from the Swedish National Patient Register using ICD-8, ICD-9 and ICD-10 codes and procedure codes. Reporting to the National Patient Register is mandatory for all health care providers, which has information on inpatient diagnoses and procedures beginning in 1964, with complete national coverage since 1987 and with outpatient records since 2001.[@b21-clep-10-971],[@b22-clep-10-971] In addition to using the Patient Register, diagnoses of diabetes and hyperlipidemia were additionally also identified using the Swedish Prescribed Drug Register, which covers all prescribed medications collected by patients since July 1, 2005.[@b23-clep-10-971]

The cohort comprised ostensibly healthy adolescent men at the time of conscription examination with complete data for measures used in the analysis and without diagnosed kidney disease prior to pneumonia. Exclusions were made for data inconsistencies including incorrect personal identification number (n=2,564); improbable measures at the conscription assessment (n=225); no conscription assessment due to chronic illness, disability, lack of Swedish citizenship or incarceration (n=16,458); missing data (n=21,837); and conscription assessment outside ages 16--20 years (n=3,176). Men with diagnoses at conscription assessment consistent with kidney dysfunction, including trace or positive dipstick proteinuria; chronic inflammatory disease (vasculitis, rheumatoid arthritis and other collagenosis); and men with CVD or malformations of the urogenital or cardiovascular system at conscription assessment were excluded (n= 12,426). Finally, all men diagnosed with polycystic kidney disease at any time during follow-up were excluded (n=148). A total of 227,364 men (80% of the birth cohort) remained in the analytical sample.

Exposure
--------

After the conscription assessment, hospital discharge records were used to identify diagnoses of pneumonia without contemporaneous kidney disease in men without any previously recorded kidney disease. Diagnoses of pneumonia were considered as separate episodes if the discharge diagnoses were more than 30 days apart.

Outcome
-------

The outcome CKD was based on the first occurrence of the following conditions in the National Patient Register: kidney failure, ESRD, glomerulonephritis, nephrotic syndrome, diabetic nephropathy, nephrosclerosis or hypertensive kidney disease. This wide definition was chosen due to the large proportion of CKD patients who receive a diagnosis without a kidney biopsy, which in our sample was 91.5% (2,639/2,885). ESRD was defined as long-term dialysis therapy, kidney transplantation, surgical procedures creating long-term access for dialysis or a diagnosis indicating stage 5 CKD.

Covariates
----------

From the baseline conscription examination, established risk factors for CKD and measures previously associated with future ESRD in the same cohort were included as covariates. Erythrocyte sedimentation rate as determined by the Westergren method was adjusted for the erythrocyte volume fraction (microhematocrit method) in the analysis.[@b24-clep-10-971] Systolic blood pressure and diastolic blood pressure measured after rest in a recumbent position using a sphygmomanometer were categorized as optimal (systolic \<120 mmHg and diastolic \<80 mmHg), normal (120--129/80--84 mmHg), high-normal (130--139/85--89 mmHg), grade 1 hypertension (140--159/90--99 mmHg), grade 2 hypertension (160--179/100--109 mmHg) and grade 3 hypertension (\>180/\>110 mmHg).[@b25-clep-10-971] Grades 2 and 3 hypertension were collapsed into a single category due to small numbers. Body mass index (BMI) categories were calculated from weight and height measured in light clothing without shoes. Physical working capacity was assessed using an electronically braked ergometer with the maximum load sustained for 6 minutes and summarized in a 0- to 9-point score.[@b26-clep-10-971] A cognitive function assessment covering linguistic understanding, spatial recognition, general knowledge and ability to follow mechanical instructions produced a 9-point score.[@b27-clep-10-971]

Head of household's occupation and household crowding (quarters of the distribution of persons per habitable room ratio) in childhood from the 1960 census were included to account for socioeconomic conditions for the family of origin.

Statistical analysis
--------------------

Descriptive statistics for exposed and unexposed men were compared using the two-sample *t*-test for continuous measures and Pearson's chi-squared test for categorical measures.[@b28-clep-10-971],[@b29-clep-10-971] Associations between hospital admission with pneumonia and subsequent CKD were evaluated using Cox regression with attained age as the underlying timescale.[@b30-clep-10-971] Follow-up began 1 year after the first episode of hospital admission with pneumonia, and the study population was followed up until date of first incident diagnosis of kidney disease, death, emigration or December 31, 2009, whichever occurred first. Due to evidence of non-proportional hazards, follow-up time was divided into categories (≤5, \>5−≤15 and \>15 years). There was no evidence of violation of the proportional hazards assumption, tested using scaled Schoenfeld residuals, for these periods.[@b31-clep-10-971] For each period, model fit was tested using the added variable version of the Gronnesby and Borgan test.[@b32-clep-10-971] Adjusted models included all measures described in covariates section. All statistical analyses were conducted using STATA 14 (Stata Corp., College Station, TX, USA) or SPSS 22.0 (IBM Corp., Armonk, NY, USA).

Sensitivity analyses
--------------------

The main analysis was repeated only considering pneumonia as the primary diagnosis at hospital discharge, and we also evaluated the effect of adjusting for repeated pneumonia episodes. Separate analyses excluded from the outcome acute kidney failure and diabetic nephropathy; and excluded from the study base were men ever diagnosed with sepsis, and men ever diagnosed with chronic obstructive pulmonary disease (COPD). Additionally, we restricted the outcome to ESRD, and collapsed the final two periods of follow-up time after pneumonia (\>5−≤15 and \>15 years) due to low numbers. Additional adjustment was undertaken for CVD, diabetes and hyperlipidemia, modeled as time-dependent covariates.

To further tackle possible residual confounding by comorbidity and to reduce surveillance bias, the sample was restricted to include only men who had at least one hospital discharge diagnosis during adulthood. We applied incidence density sampling without replacement of unexposed to create nested matched cohorts.[@b33-clep-10-971] Each man with pneumonia (at risk of CKD) was matched with five unexposed men (at risk of CKD and pneumonia) by birth year, month and year of discharge (index date), censored at the time of first pneumonia diagnosis.[@b34-clep-10-971] In these nested cohorts, additional adjustments were included for adult diabetes and CVD recorded in the National Patient Register before or on the index date.

Results
=======

The population is described in [Table 1](#t1-clep-10-971){ref-type="table"}. During a median duration from study entry in late adolescence of 36.7 (interquartile range 35.3--37.9) years, 5,822 men had an inpatient pneumonia diagnosis without contemporaneous kidney disease. Among exposed men, 136 were diagnosed with CKD (19.34 per 10,000 person-years, 95% confidence interval 16.35--22.88) compared with 2,749 of the unexposed men (3.47 per 10,000 person-years, 95% confidence interval 3.40--3.60), representing an increased relative risk of 88.3%. No men were lost to follow-up within Sweden since the unique Swedish personal identification number allows full coverage in national registers. The pattern of censoring of exposed and unexposed men is included in [Figure 1](#f1-clep-10-971){ref-type="fig"}. The Gronnesby and Borgan test did not indicate inadequate model fit for any of the periods following exposure (*P*\>0.05). The unadjusted and adjusted hazard ratios for CKD in the excluded first year after pneumonia are 15.81 (11.32--22.07) and 14.55 (10.41--20.32), respectively, identifying early onset kidney complications and possibly pre-existing undiagnosed kidney disease. Before the end of follow-up, 19.9% of the exposed men with CKD progressed to ESRD.

Starting follow-up 1 year after pneumonia to reduce surveillance bias and the risk of reverse causation, the adjusted hazard ratio for CKD diagnosed in the first 5 years of follow-up is 5.20 (3.91--6.93). Hazard ratios for CKD following pneumonia are presented in [Table 2](#t2-clep-10-971){ref-type="table"}. There is an initial high magnitude risk during the first 5 years, which attenuates somewhat over time, but remains statistically significant more than 15 years after the pneumonia diagnosis. All covariates are statistically significantly associated with CKD in unadjusted analysis. The most notable associations with increased risk for CKD in the adjusted model are high BMI, low physical working capacity, low cognitive function score and greater household crowding ([Table S2](https://www.dovepress.com/get_supplementary_file.php%3Ff%3D169039.pdf)). Adjustment has no major influence on the association of pneumonia with CKD.

Sensitivity analyses
--------------------

Results from the sensitivity analyses performed in the main cohort are included in [Table 2](#t2-clep-10-971){ref-type="table"}. After additional adjustment for CVD, diabetes and hyperlipidemia as time-dependent covariates, the magnitudes of the hazard ratios for the main results were attenuated moderately but they remained statistically significant for all time periods between pneumonia and CKD; the results look more similar to those from the matched hospital cohort. The remaining sensitivity analyses do not indicate any notable change in the associations; the association of pneumonia with CKD is not explained by multiple pneumonia episodes. When restricting the outcome to ESRD, the unadjusted and adjusted hazard ratios during the first 5 years of follow-up were 6.22 (3.42--11.32) and 5.72 (3.14--10.41), respectively, attenuating to 2.20 (1.17--4.12) and 2.15 (1.15--4.03) in the remaining years of follow-up. The nested matched hospital cohorts comprised 99.9% (5,814/5,822) of the exposed men, who could be matched successfully with five unexposed men. Median follow-up was 10.7 years (interquartile range 3.8--18.6). Characteristics of the nested matched cohorts (men were inpatients in both cohorts) are given in [Table S3](https://www.dovepress.com/get_supplementary_file.php%3Ff%3D169039.pdf), and censoring patterns are detailed in [Table S4](https://www.dovepress.com/get_supplementary_file.php%3Ff%3D169039.pdf). The unadjusted hazard ratio for CKD during the first 5 years of follow-up was 2.81 (1.97--4.02) and using a model adjusted for characteristics in childhood and adolescence, and CVD and diabetes in adulthood, the hazard ratio was 2.85 (1.84--4.41). Hazard ratios during the following 10 years of follow-up were 2.13 (1.42--3.20) and 1.75 (1.09--2.82) for unadjusted and adjusted models, respectively.

Discussion
==========

In this large national cohort study of men in Sweden, hospital admission with pneumonia was associated with a persistent increased risk for subsequent CKD, particularly during the first 5 years of follow-up beginning 1 year after the infection. Although attenuated over time, the raised risk remained statistically significant for more than 15 years. The association was independent of measures in childhood and adolescence previously associated with ESRD in the same cohort.[@b17-clep-10-971] The association was robust, as indicated by the results of a number of sensitivity analyses addressing possible confounding by comorbidity, repeated pneumonia episodes, and sepsis or acute kidney failure. The results from an additional analysis of nested matched cohorts of men who had all been hospital inpatients indicate that neither contemporaneous diabetes or CVD at the time of the pneumonia episode nor surveillance or selection bias seem to explain the findings. Further analysis of the main cohort with additional adjustment for timing of diagnoses for diabetes, CVD and hyperlipidemia suggest that although these types of comorbidity are associated with a higher magnitude risk of CKD following pneumonia, a history of inpatient care with pneumonia identifies a statistically significant independent risk. The maximum age of men in this study was only 57 years, and so a larger proportion with pneumonia and CKD may be expected in an older population.

Our study has potential limitations. Given the limitations of the administrative dataset, the CKD outcome comprises a heterogeneous mix of diagnoses rather than information on estimated glomerular filtration rate and proteinuria, which would provide higher sensitivity for detection of CKD and allow grading of CKD stage. However, treating these diagnoses as a common entity rather than separate outcomes is reasonable, given the low number of kidney biopsies performed in clinical practice and diagnoses based on reduced kidney function without identifying the etiology. Sensitivity analysis excluding some diagnoses did not alter the findings notably. The binary nature of the CKD outcome limits evaluation of its clinical significance, although increasing severity of kidney disease would be recorded in the discharge summary to an increasing extent. The results were similar when the outcome was limited to ESRD. The potential underestimation of the incidence of CKD applies equally to exposed and unexposed men and would be expected to dilute rather than cause a spurious association. Non-detection of pre-existing CKD at the pneumonia episode may also introduce reverse causation. However, the increased susceptibility to infections associated with CKD is mainly seen in moderate and advanced disease, which should be recorded in the discharge summaries.[@b35-clep-10-971],[@b36-clep-10-971] Exclusion of CKD diagnoses in the first year after discharge will also tackle this problem, even though it produces a substantially lower magnitude association. Thus, our main findings are likely to underestimate the risk of CKD following pneumonia, but this is preferable to the spuriously inflated estimates that may occur if the first year after infection is included. Hospital discharge records do not separate acute kidney failure with complete remission from cases resulting in CKD. In sensitivity analyses excluding acute kidney failure from our definition of CKD, no effect on the associations was evident. Pneumonia is associated with an increased short-term and long-term mortality and we did not evaluate competing risks.[@b4-clep-10-971],[@b11-clep-10-971],[@b13-clep-10-971] Although the competing event, death without diagnosed CKD, occurred in a substantially higher proportion of exposed men, it does not change our key finding of an increased risk of CKD following pneumonia for men still at risk.

Measures of proteinuria, BMI and blood pressure were only available from the initial conscription assessment and we did not have information on smoking. Our results were robust in sensitivity analysis excluding patients with COPD and signaling smoking, although of course not identifying all smokers. There is a possibility of confounding by comorbidity, but exclusion of events in the first year after pneumonia, sensitivity analysis with additional adjustment for CVD, diabetes and hyperlipidemia as time-dependent covariates and creation of matched hospital inpatient cohorts allowing adjustment for additional risk factors in adulthood make this less likely to be a major limitation. Comparing hospital cohorts may underestimate the magnitude of risk as the unexposed hospital patients may carry more risks for CKD than the general population. Whether or not hospital admission with pneumonia has a causal association with CKD, it serves to identify patients at increased risk of developing CKD. The study population comprised only men due to the use of military conscription assessment data. There are potential sex differences in the underlying pathophysiology of CKD, which may limit the generalizability of our results to women.[@b37-clep-10-971],[@b38-clep-10-971]

Our study also has several major strengths, including characterization of the temporal pattern of the association between pneumonia and CKD, the large general population based sample of men, long-term follow-up, the availability of initial clinical conscription assessment data before follow-up and the flexibility to create nested cohorts of men who were all admitted to hospital to further tackle potential surveillance and selection bias.

To our knowledge, only one previous study has evaluated the potential long-term risks for CKD following pneumonia in adults. Huang et al performed a population-based retrospective cohort study based on claims data in Taiwan's National Health Insurance Research Database to assess ESRD risk during 13 years of follow-up for patients admitted to hospital with pneumococcal pneumonia.[@b7-clep-10-971] The unexposed were not required to be inpatients. The overall adjusted hazard ratio for ESRD associated with pneumonia (1.14, 95% confidence interval: 1.01--1.29) indicated a statistically significant slight increase in ESRD risk. ESRD risk in different time-periods following pneumonia was not evaluated. Taiwan has the highest incidence and prevalence of ESRD in the world, despite a prevalence of CKD comparable to other Asians and western countries and this has been suggested to indicate an underestimation of CKD prevalence in Taiwan.[@b39-clep-10-971] There are also differences in the pattern of CKD etiology between Asia and Europe, including a more important role for chronic infections (HIV, hepatitis), CKD from herbal medications and tropical infections with potential kidney sequelae.[@b39-clep-10-971],[@b40-clep-10-971] Our study undertaken in a European setting adds characterization of the temporal pattern of risk, evaluation of not only ESRD but CKD risk in general, a longer follow-up, addresses potential selection and surveillance bias in the nested matched hospital cohorts, and is not restricted to pneumococcal pneumonia.

There are several possible explanations for the notable increase in CKD risk associated with hospital admission with pneumonia. Individuals with immunodeficiency are at increased risk of pneumonia and there is also an association between immunodeficiency and autoimmunity, possibly causing CKD.[@b1-clep-10-971],[@b41-clep-10-971] However, more severe immunodeficiency is likely to be associated with repeated episodes of hospital admissions with pneumonia, and adjusting for repeated exposures had no major effect on the associations. Several markers of inflammation are associated with future incident CKD, and progression of established CKD and pneumonia has the potential to cause persistent low-grade systemic inflammation. Although the majority of inpatients with pneumonia recover clinically within 1 week, markers of systemic inflammation remain elevated in more than 50% of patients; the mean circulating C-reactive protein level 6 months after pneumonia has been reported to be elevated (5 mg/L).[@b12-clep-10-971],[@b42-clep-10-971],[@b43-clep-10-971]

Our results have implications for clinicians and policy makers. Increased risks for mortality, CVD, congestive heart failure and, as indicated by our study, CKD extend for at least a decade after an episode of pneumonia.[@b2-clep-10-971]--[@b6-clep-10-971] Increased awareness of the initial period of high-magnitude CKD risk following pneumonia could facilitate early diagnosis and secondary preventive interventions. The expanding insights into the adverse consequences of pneumonia may necessitate a future re-evaluation of the costs and benefits of pneumococcal vaccination.

Conclusion
==========

Hospital admission with pneumonia in adulthood indicates a future increased risk of CKD, most notably during the first 5 years, indicating a possible target period for early detection and secondary preventive interventions.
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**Abbreviation:** CKD, chronic kidney disease.](clep-10-971Fig1){#f1-clep-10-971}

###### 

Characteristics of men with and without pneumonia

  Characteristic                                                                      Unexposed (n=221,542)   Exposed (n=5,822)                                             *P*
  ----------------------------------------------------------------------------------- ----------------------- ------------------------------------------------------------- ---------
  CKD                                                                                 2,749 (1.2%)            136 (2.3%)                                                    \<0.001
   CKD≥1year after pneumonia                                                          n/a                     101 (1.7%)                                                    
   CKD \<1 year after pneumonia                                                       n/a                     35 (0.6%)                                                     
  Years of follow-up before pneumonia                                                 n/a                     24.7 (16.6−31.9)[c](#tfn4-clep-10-971){ref-type="table-fn"}   
  Year of birth                                                                                                                                                             
   1952                                                                               43,469 (19.6%)          1,274 (21.9%)                                                 \<0.001
   1953                                                                               43,086 (19.4%)          1,127 (19.4%)                                                 
   1954                                                                               43,973 (19.8%)          1,135 (19.5%)                                                 
   1955                                                                               45,104 (20.4%)          1,183 (20.3%)                                                 
   1956                                                                               45,910 (20.7%)          1,103 (18.9%)                                                 
  Age at conscription assessment (years)[a](#tfn2-clep-10-971){ref-type="table-fn"}                                                                                         
   16                                                                                 89 (0.04%)              1 (\<0.1%)                                                    \<0.001
   17                                                                                 778 (0.4%)              17 (0.3%)                                                     
   18                                                                                 109,321 (49.3%)         2,566 (44.1%)                                                 
   19                                                                                 102,673 (46.3%)         2,917 (50.1%)                                                 
   20                                                                                 8,681 (3.9%)            321 (5.5%)                                                    
  Body mass index[a](#tfn2-clep-10-971){ref-type="table-fn"}                                                                                                                
   Underweight                                                                        25,458 (11.5%)          772 (13.3%)                                                   \<0.001
   Normal                                                                             179,574 (81.1%)         4,518 (77.6%)                                                 
   Overweight                                                                         14,373 (6.5%)           449 (7.7%)                                                    
   Obese                                                                              2,137 (1.0%)            83 (1.4%)                                                     
  Hypertension[a](#tfn2-clep-10-971){ref-type="table-fn"}                                                                                                                   
   Optimal                                                                            39,484 (17.8%)          1,077 (18.5%)                                                 \<0.01
   Normal                                                                             75,203 (33.9%)          2,067 (35.5%)                                                 
   High normal                                                                        65,790 (29.7%)          1,691 (29.0%)                                                 
   Grade 1                                                                            39,525 (17.8%)          952 (16.4%)                                                   
   Grade 2, 3                                                                         1,540 (0.7%)            35 (0.6%)                                                     
  Erythrocyte sedimentation rate[a](#tfn2-clep-10-971){ref-type="table-fn"}                                                                                                 
   0--1 mm                                                                            52,462 (23.7%)          1,387 (23.8%)                                                 0.60
   2--6 mm                                                                            146,275 (66.0%)         3,809 (65.4%)                                                 
   7--10 mm                                                                           14,603 (6.6%)           392 (6.7%)                                                    
   11--14 mm                                                                          4,426 (2.0%)            119 (2.0%)                                                    
   ≥15 mm                                                                             3,776 (1.7%)            115 (2.0%)                                                    
  Erythrocyte volume fraction[a](#tfn2-clep-10-971){ref-type="table-fn"}              46.41 (2.41)            46.48 (2.45)                                                  0.04
  Mean (SD) physical working capacity[a](#tfn2-clep-10-971){ref-type="table-fn"}      6.33 (1.81)             6.05 (1.83)                                                   \<0.001
  Mean (SD) IQ score[a](#tfn2-clep-10-971){ref-type="table-fn"}                       5.22 (1.97)             4.80 (2.05)                                                   \<0.001
  Household crowding (quantiles)[b](#tfn3-clep-10-971){ref-type="table-fn"}                                                                                                 
   1 Lowest                                                                           57,715 (26.1%)          1,382 (23.7%)                                                 \<0.001
   2                                                                                  68,616 (31.0%)          1,771 (30.4%)                                                 
   3                                                                                  47,272 (21.3%)          1,292 (22.2%)                                                 
   4 Highest                                                                          47,939 (21.6%)          1,377 (23.7%)                                                 
  Head of household's occupation[b](#tfn3-clep-10-971){ref-type="table-fn"}                                                                                                 
   Manual/agricultural work                                                           100,034 (45.2%)         2,751 (47.3%)                                                 \<0.001
   Farm owners/managers                                                               22,308 (10.1%)          513 (8.8%)                                                    
   Office workers                                                                     61,767 (27.9%)          1,549 (26.6%)                                                 
   Business owners/managers                                                           24,025 (10.8%)          587 (10.1%)                                                   
   Others                                                                             13,408 (6.1%)           422 (7.2%)                                                    

**Notes:** Values are numbers (with %) unless stated otherwise.

Indicates measures from conscription assessment.

Indicates measures in childhood.

Median (interquartile range). Groups are compared using Pearson's chi-squared test and continuous measures using two-sample t-test.

**Abbreviations:** CKD, chronic kidney disease; n/a, not applicable.

###### 

Associations of pneumonia with chronic kidney disease during time periods following hospital admission with pneumonia

  Analysis                                                               Exposed   Unadjusted[a](#tfn6-clep-10-971){ref-type="table-fn"}   Adjusted model[b](#tfn7-clep-10-971){ref-type="table-fn"}                                          
  ---------------------------------------------------------------------- --------- ------------------------------------------------------- ----------------------------------------------------------- --------- ------------------ --------- --
  Main analysis                                                                                                                                                                                                                               
   ≥5 years                                                              5,157     48                                                      5.63 (4.23−7.49)                                            \<0.001   5.20 (3.91−6.93)   \<0.001   
   \>5--≤ 15 years                                                       3,672     34                                                      2.90 (2.07−4.07)                                            \<0.001   2.80 (1.99−3.93)   \<0.001   
   \> 15 years                                                           1,838     19                                                      2.17 (1.38−3.42)                                            \<0.001   2.13 (1.35−3.35)   \<0.01    
  Pneumonia as primary diagnosis                                                                                                                                                                                                              
   ≥5 years                                                              4,062     31                                                      4.60 (3.22−6.55)                                            \<0.001   4.30 (3.01−6.13)   \<0.001   
   \>5--≤ 15 years                                                       3,017     26                                                      2.64 (1.79−3.88)                                            \<0.001   2.57 (1.74−3.78)   \<0.001   
   \>15 years                                                            1,589     15                                                      1.93 (1.16−3.21)                                            0.01      1.89 (1.13−3.14)   0.01      
  Adjusted for repeated exposures                                                                                                                                                                                                             
   ≥5 years                                                              5,157     48                                                      5.29 (3.95−7.10)                                            \<0.001   4.94 (3.68−6.62)   \<0.001   
   \>5--≤ 15 years                                                       3,672     34                                                      2.74 (1.94−3.86)                                            \<0.001   2.66 (1.89−3.76)   \<0.001   
   \>15 years                                                            1,838     19                                                      2.06 (1.31−3.25)                                            \<0.01    2.03 (1.29−3.21)   \<0.01    
  Not including acute kidney failure                                                                                                                                                                                                          
   ≤5 years                                                              5,162     34                                                      4.75 (3.38−6.67)                                            \<0.001   4.42 (3.15−6.21)   \<0.001   
   \>5--≤ 15 years                                                       3,676     24                                                      2.48 (1.66−3.72)                                            \<0.001   2.41 (1.61−3.60)   \<0.001   
   \>15 years                                                            1,839     15                                                      2.11 (1.27−3.51)                                            \<0.01    2.07 (1.24−3.44)   \<0.01    
  Not including diabetic nephropathy                                                                                                                                                                                                          
   ≤5 years                                                              5,158     42                                                      5.78 (4.26−7.85)                                            \<0.001   5.41 (3.98−7.35)   \<0.001   
   \>5--≤ 15 years                                                       3,677     29                                                      2.97 (2.06−4.29)                                            \<0.001   2.87 (1.99−4.14)   \<0.001   
   \>15 years                                                            1,840     18                                                      2.50 (1.57−3.99)                                            \<0.001   2.44 (1.53−3.89)   \<0.001   
  Excluding men with COPD                                                                                                                                                                                                                     
   ≤5 years                                                              4,936     46                                                      5.77 (4.31−7.73)                                            \<0.001   5.39 (4.02−7.22)   \<0.001   
   \>5--≤ 15 years                                                       3,545     31                                                      2.81 (1.97−4.00)                                            \<0.001   2.72 (1.91−3.89)   \<0.001   
   \>15 years                                                            1,784     15                                                      1.81 (1.09−3.01)                                            0.02      1.79 (1.07−2.97)   0.02      
  Excluding men with sepsis                                                                                                                                                                                                                   
   ≤5 years                                                              4,631     29                                                      4.31 (2.99−6.22)                                            \<0.001   4.04 (2.80−5.83)   \<0.001   
   \>5--≤ 15 years                                                       3,346     24                                                      2.58 (1.72−3.86)                                            \<0.001   2.50 (1.67−3.75)   \<0.001   
   \>15 years                                                            1,732     15                                                      2.04 (1.23−3.40)                                            \<0.01    2.01 (1.21−3.35)   \<0.01    
  Comorbidity, time varying[c](#tfn8-clep-10-971){ref-type="table-fn"}                                                                                                                                                                        
   ≤5 years                                                              5,157     48                                                      n/a                                                                   2.44 (1.82−3.25)   \<0.001   
   \>5--≤ 15 years                                                       3,672     34                                                      n/a                                                                   1.69 (1.20−2.38)   \<0.01    
   \>15 years                                                            1,838     19                                                      n/a                                                                   1.66 (1.06−2.62)   0.03      

**Notes:**

Follow-up time starting 1 year after pneumonia.

Adjusted for characteristics in adolescence (body mass index, blood pressure, physical working capacity, cognitive function, erythrocyte sedimentation rate, erythrocyte volume fraction) and childhood (household crowding and head of household's occupation).

Additionally adjusted for cardiovascular disease, diabetes and hyperlipidemia as time varying covariates.

**Abbreviations:** CI, confidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard ratio.
